Drugs with verified catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

598 drugs/products referenced in verified catalyst events. Verified as of 2026-11-04.

Drug	Catalysts
BOSENTAN	7
TPSAC	4
Drug: 5 mg BGM0504 Administered SC, Drug: : 10 mg BGM0504 Administered SC, Drug: Placebo Administered SC	2
Efanesoctocog alfa	2
Satralizumab	2
FDORA	2
Investigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine, Hepatitis A vaccine	2
KarXT	2
TAK-360	2
Kedrion IVIG 10%	2
olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin (preferred) or cisplatin, Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin, Bevacizumab (or biosimilar)	2
APG-157	2
Resmetirom	2
RLS-0071	2
Artesunate ointment	2
Ebselen	2
Solriamfetol 150 mg, Solriamfetol 300 mg	2
Lutikizumab	2
PCV21, 20vPCV	2
ENV-294	2
Cariprazine	2
Corabotase	2
brivekimig	2
Bimekizumab	2
QRX003, 4% Lotion	2
Afimkibart	2
Upadacitinib	2
Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%, Vehicle containing excipients only (VEH) without active ingredient, Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E	2
Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle	2
AZD0780	2
RSVpreF	2
Maridebart Cafraglutide	2
Suzetrigine	2
Xeomin	2
TRACLEER	2
COVID	2
dabrafenib, trametinib	1
Parsaclisib, parsaclisib + itacitinib, parsaclisib + ruxolitinib, parsaclisib + ibrutinib	1
AZD9750, AZD5305	1
Pembrolizumab, Dostarlimab, Belrestotug, Nelistotug	1
PRGN-2009 plus Pembrolizumab	1
PF-07275315, PF-07264660	1
REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab	1
Inavolisib, Fulvestrant, Alpelisib, Bupropion	1
Olatorepatide	1
Metaxalone 640 mg Oral Tablet	1
PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution	1
Zilucoplan	1
AZD0901, 5-Fluorouracil, Leucovorin, l-leucovorin	1
ETOPOSIDE - Usual, ETOPOSIDE - Study	1
Abiraterone - Usual, Abiraterone - Study	1
Deucravacitinib	1
ALECENSA - alectinib hydrochloride capsule	1
SMS001	1
Emicizumab	1
RO7269162	1
JNJ-95597528	1
Pembrolizumab, Carboplatin, Paclitaxel, Docetaxel	1
povorcitinib, ICS-LABA	1
Nimacimab injection, Nimacimab placebo injection, semaglutide injection, Nimacimab 300 mg injection	1
Dostarlimab, CAPEOX	1
Avelumab	1
AZD0754, AZD2287	1
TX000045- Dose A, TX000045- Dose B	1
Dostarlimab, Carboplatin, Paclitaxel, Niraparib	1
Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M	1
TB006	1
Yellow fever vaccine (live), Yellow fever vaccine (live), Yellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenuated	1
Rimegepant, Rimegepant	1
Perillyl alcohol	1
Atezolizumab, Bevacizumab	1
SGT-001	1
CC-92480, Bortezomib, Dexamethasone, Daratumumab	1
Alectinib, Entrectinib, Vemurafenib, Cobimetinib	1
Anvumetostat, Docetaxel, Comparator Anvumetostat Test Tablet	1
mRNA-3745	1
Leniolisib	1
AVTX-803 (L-Fucose)	1
ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan	1
AAV9-hSyn1-miGRIK2	1
AU-011, SCS Microinjector, Laser	1
D-0502, Fulvestrant	1
ARV-806	1
Jynneos, MVA-BN (Quail)	1
rilzabrutinib	1
SL1002, Normal Saline	1
MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)	1
Oral BGE-102, Oral Placebo Matching BGE-102	1
KarXT, Trimethobenzamide, Ondansetron, Meclizine	1
Selinexor, Selinexor, Selinexor	1
LUM015, LUM 2.6 Imaging Device	1
ACIT-1	1
relacorilant	1
Ralinepag	1
Apalutamide, Androgen Deprivation Therapy (ADT)	1
T89 capsule	1
Ruvidar® (TLD-1433) bladder infusion and PDT	1
BRTX-100, Saline	1
PMD-026, fulvestrant	1
Low Dose Budesonide, High Dose Budesonide	1
Selinexor (combination therapy), Selinexor (combination therapy), Selinexor (combination therapy), Rituximab (combination therapy)	1
PRL3-zumab	1
ST101, Temozolomide, Radiation	1
RPESC-RPE-4W	1
AdAPT-001, Checkpoint Inhibitor, Immune	1
ABBV-RGX-314, ABBV-RGX-314, Ranibizumab (LUCENTIS®)	1
ARX788	1
Atenativ	1
ZEN003694, Enzalutamide	1
Recombinant human tissue kallikrein	1
azenosertib	1
HEC585 dose A, HEC585 dose B	1
CR6086, AGEN2034	1
DNL593	1
Elacestrant, Abemaciclib	1
Donidalorsen	1
anitocabtagene-autoleucel	1
Masupirdine 50 mg, Masupirdine 100 mg	1
Evexomostat	1
LP-300, Pemetrexed, Carboplatin	1
STP938	1
AP203, AP203	1
DR-01	1
RYZ101, Everolimus, Sunitinib, Octreotide	1
AMDX-2011P	1
TAS-120	1
A2B530, xT-Onco with HLA-LOH Assay	1
ZT-01, 7 mg, ZT-01, 15 mg, ZT-01, 22 mg	1
Iltamiocel	1
TU2218 + KEYTRUDA® (Pembrolizumab)	1
TTX-381, TTX-381	1
TARA-002	1
BEAM-201	1
ALTO-300	1
CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs), Diagnostic Catheterization	1
Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice	1
nab-sirolimus	1
Descartes-08	1
NS-229	1
BN104 monotherapy, BN104 monotherapy, BN104 monotherapy - rp2d	1
RABI-767	1
NXC-201 CAR-T	1
ABBV-400, Bevacizumab, Folinic Acid, Fluorouracil	1
LX2020	1
BHV-7000, BHV-7000, BHV-7000	1
AT-1965 Liposome Injection	1
EIK1001, Pembrolizumab, Paclitaxel, Pemetrexed	1
MT218 injection	1
ZILRETTA	1
Seralutinib, Gereic Dry Powder Inhaler	1
LAT010, LAT010 + ICI	1
STIMULAN VG	1
OMS906 study drug	1
WGI-0301 at MTD/RP2D dose IV infusion, QW, WGI-0301 at MTD/RP2D -1 dose IV infusion, QW, Sorafenib 400 mg PO, BID continuously, Sorafenib 400 mg PO, BID	1
OCTA-C1-INH	1
ETX-19477	1
NoNO-42	1
NMD670	1
BO-112	1
GIM-531, Anti-PD-1 monoclonal antibody	1
BHV-7000, BHV-7000	1
Obefazimod	1
Claseprubart	1
EscharEx (EX-03)	1
AGA2118	1
SA53-OS (phase 1), SA53-OS (phase 2)	1
SHJ002, Atropine	1
Budesonide	1
Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil plus Bevacizumab Alone	1
RNK08954-01	1
Felzartamab	1
TR987 0.1% gel + Standard of Care	1
Crofelemer Powder for Oral Solution	1
ORX750	1
CNP-103	1
Stem cell, Genetic Screening, Genetic Reprogramming, Cell Maturation	1
navenibart	1
Halneuron, Halneuron (Open Label Extension)	1
d-MAPPS, PI and Patient Masked	1
Pandemic flu H5 HA mRNA SD2 vaccine	1
human retinal progenitor cells, Mock injection	1
VDPHL01	1
KB801	1
1.0mg/kg/day PRAX-562, 1.5mg/kg/day PRAX-562	1
KB803	1
1mg elsunersen, 0.5mg elsunersen	1
Ninerafaxstat 200mg MR	1
nemolizumab	1
Tobevibart, Elebsiran, Bulevirtide	1
EC5026 oral tablet	1
LY3537021, Background Chemotherapy	1
EL219, Active Comparator- IV Antifungal (LAmB or voriconazole)	1
VQW-765	1
VENT-03	1
inhaled mosliciguat, Dry Powder Inhaler	1
ICM ADX-2191 injection, Monthly ADX-2191 injection	1
Tradipitant	1
zelicapavir	1
Abenacianine, Near Infrared (NIR) Imaging	1
Tonlamarsen	1
AL001, Lithium carbonate	1
Artificial Tear Run-in, licaminlimab, Vehicle of licaminlimab	1
Rademikibart	1
TRIESENCE (triamcinolone acetonide injectable suspension)	1
Ritlecitinib higher dose, Ritlecitinib lower dose	1
REGN7999	1
E2814, Lecanemab	1
VLA15	1
Milvexian, Apixaban, Apixaban Placebo	1
Ritlecitinib	1
zongertinib, pembrolizumab, cisplatin, carboplatin	1
Baxdrostat/dapagliflozin, Baxdrostat/Placebo	1
Momelotinib	1
disitamab vedotin, pembrolizumab	1
mRNA-1273, mRNA-1283	1
AAA617, 68Ga-PSMA-11	1
BMS-986435	1
ABP 234, Pembrolizumab	1
Delgocitinib cream, Vehicle cream	1
NNC0662-0419	1
rezatapopt, pembrolizumab	1
Nipocalimab	1
GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®]	1
XL092, Nivolumab, Sunitinib Malate	1
Gefurulimab	1
Acoustic Cluster Therapy, Modified FOLFIRINOX	1
White petrolatum, Investigational moisturizer	1
BMS-986446	1
SAR442970	1
TAK-861	1
Raloxifene - Usual, Raloxifene - Study	1
Topotecan - usual, Topotecan - study	1
Belzutifan, Palbociclib	1
JNJ-64042056	1
BI 1584862	1
Ixo-vec, Aflibercept	1
Benralizumab	1
AAA617, AAA517, Piflufolastat F 18, ARPI	1
CHO-H01, CHO-H01 at RP2D, Lenalidomide	1
FPI-2265	1
frexalimab, brivekimig, rilzabrutinib	1
Investigational varicella vaccine_Lot 1, Investigational varicella vaccine_Lot 2, Investigational varicella vaccine_Lot 3, Marketed varicella vaccine_Lot 1	1
Ritlecitinib 50 mg, Ritlecitinib 100 mg	1
Oregovomab, Paclitaxel, Carboplatin, Carboplatin	1
Povorcitinib	1
Elacestrant, Alpelisib, Everolimus, Ribociclib	1
DFL24498, Vehicle	1
EGCG and Quinine Sulfate Vaginal Suppository	1
Niraparib	1
Artesunate	1
Alirocumab	1
everolimus	1
Nivolumab Injectable Product, Trans-arterial tirapazamine embolization	1
Pazopanib, Abexinostat	1
BS01	1
SLS009, venetoclax, azacitidine	1
Cetrelimab, TAR-200, Cisplatin, Gemcitabine	1
NEO100	1
NRC-2694-A, Paclitaxel	1
Oregovomab, Niraparib	1
Vepdegestrant (ARV-471/PF-07850327), Palbociclib, Letrozole, Palbociclib	1
Iptacopan, Rituximab	1
WU-CART-007	1
AMOR-1, Crystalline Calcium Carbonate	1
Seltorexant, Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)	1
Pacritinib	1
Decartes-08	1
AK1967 (Invobenitug also known as Procizumab)	1
S-337395	1
Investigational Drug, MW-III, Silvadene® Cream 1% [Silver Sulfadiazine]	1
Pertuzumab, Trastuzumab, Other Combination Anti-Cancer Therapies	1
zenocutuzumab (MCLA-128)	1
Lecanemab IV, Lecanemab SC	1
migalastat HCl 150 mg	1
ONC-392, Pembrolizumab, Docetaxel	1
Zanubrutinib, Tislelizumab	1
BT5528, Nivolumab	1
PF-07104091 monotherapy dose escalation, PF-07104091 + palbociclib + fulvestrant, PF-07104091 + palbociclib + letrozole, PF-07104091 monotherapy dose expansion (ovarian)	1
Fuzuloparib , Abiraterone acetate and Prednisone, Fuzuloparib Placebo， Abiraterone acetate and Prednisone	1
zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine	1
nula-cel Drug Product	1
Perivascular dexamethasone, Perivascular sham	1
COVID-19 Vaccine, Diagnostic Laboratory Biomarker Analysis, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1	1
Tideglusib	1
Avelumab, Lorlatanib, Talazoparib, Pemetrexed	1
LT3001 Drug Product	1
Nivolumab Injection [Opdivo], CVM-1118	1
IMP9064	1
Durvalumab	1
CBT-001, Vehicle	1
MN-001, MN-001 placebo	1
Atezolizumab, Tobemstomig, Tiragolumab	1
Treprostinil Palmitil	1
Dapansutrile	1
Cenerimod	1
AVTX-803	1
LBS-007	1
ASKG915, Paclitaxel + Bevacizumab, Fruquintinib, Docetaxel	1
Inavolisib, Phesgo, Taxane-based Chemotherapy, Optional Endocrine Therapy of Investigator's Choice	1
CMND-100	1
CHM-2101 CAR-T cells	1
lisaftoclax +BTK inhibitor, BTK inhibitor	1
SRP-1003 IV Infusion, SRP-1003 SC Injection	1
Tenalisib	1
Lasofoxifene Tartrate	1
AB-2100	1
Navtemadlin, Navtemadlin placebo, Ruxolitinib	1
SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2	1
BI 690517, Empagliflozin	1
mRNA-1273 Variant-containing Formulation	1
LP352	1
TachoSil, Surgicel Original	1
Zanidatamab	1
Sivopixant, Acetazolamide, SASS-001	1
Enfortumab Vedotin	1
BLU-808	1
64Cu-SAR-bisPSMA	1
HBI-002, Vehicle (placebo)	1
EI-001	1
SPN-821 2400 mg	1
lotilaner, Vehicle	1
OCF001 Intravaginal Gel	1
IGV-001 Cell Immunotherapy, SOC: Temozolomide	1
BT8009, Pembrolizumab	1
Tecovirimat, Smallpox and Mpox Vaccine	1
AT-1501	1
Volixibat	1
Hemopfin+Green Light, Vehicle+Green Light	1
Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory	1
VAD044 Part I, VAD044 Part II	1
Sevasemten Dose 1, Sevasemten Dose 2, Sevasemten Dose 3, Sevasemten Dose 4	1
Tigilanol Tiglate	1
LCB84, Anti-PD-1 monoclonal antibody	1
SKG0106	1
Tilpisertib Fosmecarbil	1
Livmoniplimab, Budigalimab, Durvalumab, Atezolizumab	1
Cusatuzumab, Venetoclax, Azacitidine	1
JAB-30355, JAB-30355	1
CTI-1601	1
Sotagliflozin	1
setrusumab	1
Meropenem-Vaborbactam, Antibiotics	1
AION-301	1
CS2009, CS2009, Pemetrexed, Carboplatin	1
Autologous HB-adMSCs	1
STAR0602, Sacituzumab Govitecan (SG)	1
infigratinib 0.128 mg/kg/day, infigratinib 0.25 mg/kg/day	1
TNP-2092 for injection, Vancomycin Hydrochloride for Injection (IA), Vancomycin Hydrochloride for Injection (IV), Oral antibiotics	1
Azetukalner	1
5% TolaSure Topical Gel, Topical Placebo Gel	1
68Ga-PSMA-11	1
HM15275	1
NTX-1472	1
40 mg/day vormatrogine for 12 weeks, 30 mg/day vormatrogine for 12 weeks, 20 mg/day vormatrogine for 12 weeks	1
Antimicrobial agent	1
ABS-1230	1
0.45% SnF HW with NaF (1450 F), 67% Bicarbonate with NaF (1400 F), Colgate Cavity Protection Toothpaste	1
Cebranopadol 400 ug	1
Sonelokimab, Risankizumab	1
Anifrolumab (blinded), Anifrolumab (unblinded, open label)	1
AMG 732	1
BMS-986470, Famotidine, Pantoprazole	1
INCA034176	1
OTX-TKI, Aflibercept, Aflibercept	1
mezigdomide, Pomalidomide, Bortezomib, Dexamethasone	1
Dato-DXd, Osimertinib, Pemetrexed, Carboplatin	1
Remigromig, Ranibizumab	1
Sacituzumab Govitecan, Pembrolizumab	1
Adjuvanted RSVPreF3 vaccine	1
ABI-110 Low Dose, ABI-110 Medium Dose, ABI-110 High Dose	1
Tezepelumab	1
UBT251	1
9vHPV Vaccine	1
efanesoctocog alfa (BIVV001)	1
IDE196, Crizotinib, Pembrolizumab, Ipilimumab	1
Utidelone, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine	1
CRB-701, Anti-PD-1	1
Maribavir	1
Investigational hMPV/RSV vaccine, Investigational hMPV vaccine (monovalent), Investigational RSV vaccine (monovalent), Licensed RSV Vaccine	1
Alectinib, Entrectinib, Durvalumab	1
SAR445877, Cetuximab, ADG126, Bevacizumab	1
CELZ-201-DDT	1
GX-03, Vehicle	1
Ublituximab	1
JDQ443, TNO155, tislelizumab	1
Insulin icodec, Insulin glargine, Insulin aspart	1
Faricimab	1
FF/UMEC/VI, ELLIPTA, FF/VI	1
mRNA-1018-H5	1
IDE196, Binimetinib, Crizotinib	1
Alpelisib, Fulvestrant	1
iptacopan	1
disitamab vedotin, pembrolizumab, gemcitabine, cisplatin	1
Ziltivekimab	1
rF1V-1018, rF1V-1018, rF1V-1018, rF1V-1018	1
TOL2506, Tamoxifen, Letrozole Tablets, Anastrozole Tablets	1
Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy (Bladder and pelvic nodes), Hypofractionated Radiotherapy (Bladder only)	1
CELZ-201 Administration, Control Group	1
Cetrelimab, Amivantamab	1
Obinutuzumab, Glofitamab, Gemcitabine, Oxaliplatin	1